Knocksense: A local content and recommendations platform

{{ subpage.title }}

Bharat Biotech's nasal vaccine enters 2nd phase of human trials in Kanpur today

The second phase of human trials for the intra-nasal COVID vaccine, BBV 154, has started in Kanpur from today onwards. As per reports, this innovative vaccine has been developed by Bharat Biotech in collaboration with Washington University School of Medicine. Reportedly, the trial centre set up at Prakhar Hospital received ICMR's approval on Monday and now, the volunteers have been called for this maiden drive.

Read Now Show less